Skip to main content

Advertisement

Log in

Lymphomatosis cerebri presenting as a rapidly progressive dementia with a high methylmalonic acid

  • Original Communication
  • Published:
Journal of Neurology Aims and scope Submit manuscript

Abstract

We report a case of a patient with a rapidly progressive dementing illness and gait disturbance, in whom initial screening demonstrated a high methylmalonic acid level only, suggestive of a functional vitamin B12 deficiency. Despite B12 replacement therapy, he continued to decline. Further investigations demonstrated extensive signal change on magnetic resonance imaging involving grey and white matter within the corpus callosum, deep grey matter, brainstem and cerebellar peduncles, and patchy post-contrast enhancement. Laboratory testing revealed a raised erythrocyte sedimentation rate, raised anti-nuclear, intrinsic factor and lupus anticoagulant antibody titres, and a IgG kappa paraprotein. Cerebrospinal fluid was unremarkable. Bone marrow trephine biopsy showed monoclonal gammopathy of unknown significance. The patient initially responded to steroids, and underwent a brain biopsy, which was uninformative. However, 3 weeks following admission, he died due to an aspiration pneumonia. Autopsy findings were consistent with a diffuse primary central nervous system small cell B-cell lymphoma. This has been rarely reported in the medical literature, but our case exhibits typical clinical features, although patchy enhancement on imaging and the high methylmalonic acid have not been previously described. We hypothesise that his functional B12 deficiency may have resulted from rapid cell turnover, perhaps in conjunction with the presence of intrinsic factor antibodies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Ferreri AJ et al (2009) International Extranodal Lymphoma Study Group (IELSG). High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial. Lancet 374:1512–1520

    Article  PubMed  CAS  Google Scholar 

  2. Batchelor T, Loeffler JS (2006) Primary CNS lymphoma. J Clin Oncol 24:1281–1288

    Article  CAS  Google Scholar 

  3. Batara JF, Grossman SA (2003) Primary Central nervous system lymphoma. Curr Opin Neurol 16:671–675

    Article  Google Scholar 

  4. CBTRUS (2008). Statistical report: primary brain tumors in the United States, 2000–2004. Published by the Central Brain Tumor Registry of the United States

  5. Bühring U et al (2001) MRI features of primary central nervous system lymphomas at presentation. Neurology 57:393–396

    PubMed  Google Scholar 

  6. Küker W et al (2005) Primary central nervous system lymphomas (PCNSL): MRI features at presentation in 100 patients. J Neurooncol 72:169–177

    Article  PubMed  Google Scholar 

  7. Rollins KE, Kleinschmidt-DeMasters BK, Corboy JR, Damek DM, Filley CM (2005) Lymphomatosis cerebri as a cause of white matter dementia. Hum Pathol 36:282–290

    Article  PubMed  Google Scholar 

  8. Bakshi R et al (1999) Lymphomatosis cerebri presenting as a rapidly progressive dementia: clinical, neuroimaging and pathologic findings. Dement Geriatr Cogn Disord 10:152–157

    Article  PubMed  CAS  Google Scholar 

  9. Pandit L, Chickabasaviah Y, Raghothaman A, Mustafa S, Vasudevan A (2010) Lymphomatosis cerebri—a rare cause of leukoencephalopathy. J Neurol Sci 293(1–2):122–124

    Article  PubMed  Google Scholar 

  10. Raz E et al (2010) MRI findings in lymphomatosis cerebri: description of a case and revision of the literature. J Neuroimaging 2010 Mar 19 [epub ahead of print]

  11. Partap S, Spence AM (2006) Spontaneously relapsing and remitting primary CNS lymphoma in an immunocompetent 45-year-old man. J Neurooncol 80:305–307

    Article  PubMed  Google Scholar 

  12. Kanai R et al (2008) A case of ‘lymphomatosis cerebri’ diagnosed in an early phase and treated by whole brain radiation: case report and literature review. J Neurooncol 86:83–88

    Article  PubMed  Google Scholar 

  13. Terae S, Ogata A (1996) Nonenhancing primary central nervous system lymphoma. Neuroradiology 38:34–37

    Article  PubMed  CAS  Google Scholar 

  14. Carlson BA (1996) Rapidly progressive dementia caused by nonenhancing primary lymphoma of the central nervous system. Am J Neuroradiol 17:1695–1697

    PubMed  CAS  Google Scholar 

  15. Savage DG, Lindenbaum J, Stabler SP, Allen RH (1994) Sensitivity of serum methylmalonic acid and total homocysteine determinations for diagnosing cobalamin and folate deficiencies. Am J Med 96:239–246

    Article  PubMed  CAS  Google Scholar 

  16. Perillie PE (1978) Myeloma and pernicious anemia. Am J Med Sci 275:93–98

    Article  PubMed  CAS  Google Scholar 

  17. Baz R, Alemany C, Green R, Hussein MA (2004) Prevalence of vitamin B12 deficiency in patients with plasma cell dyscrasias: a retrospective review. Cancer 101:790–795

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

The authors wish to thank Dr Atta Siddiqui, Dept of Radiology, St Thomas’ Hospital, for his assistance with interpretation and provision of imaging, and Dr Bridget Wilkins, Dept of Histopathology, St Thomas’ Hospital, for assistance in interpreting brain and bone marrow histopathology.

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to G. Leschziner.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Leschziner, G., Rudge, P., Lucas, S. et al. Lymphomatosis cerebri presenting as a rapidly progressive dementia with a high methylmalonic acid. J Neurol 258, 1489–1493 (2011). https://doi.org/10.1007/s00415-011-5965-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-011-5965-5

Keywords

Navigation